From retrospective analysis of patients with undifferentiated spondyloarthritis (SpA) to analysis of prospective cohorts and detection of axial and peripheral SpA

Journal of Rheumatology

Volumn 37, Issue 6, 2010, Pages 1091-1095

  Burgos Vargas, Ruben ^a   Casasola Vargas, Julio C ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; ARTHRITIS; BACKACHE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; UNDIFFERENTIATED SPONDYLOARTHRITIS;

COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; RETROSPECTIVE STUDIES; SPONDYLARTHRITIS; TERMINOLOGY AS TOPIC;

EID: 77953203212     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.100413     Document Type: Editorial

References (47)

1. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907.
2. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies [French]. Rev Rhum Mal Osteoartic 1990;57:85-89
3. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-1227
4. Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF, et al. Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. J Rheumatol 1999;26:1537-1544 (Pubitemid 29317877)
5. Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, et al. Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol 2007;34:117-122 (Pubitemid 46106571)
6. Chou CT, Lin KC, Wei JC, Tsai WC, Ho HH, Hwang CM, et al. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology 2005;44:662-665
7. Porcher R, Said-Nahal R, D'Agostino MA, Miceli-Richard C, Dougados M, Breban M. Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families. Arthritis Rheum 2005;53:263-271
8. Baddoura R, Awada H, Okais J, Habis T, Attoui S, Abi Saab M. Validation of the European Spondylarthropathy Study Group and B. Amor criteria for spondylarthropathies in Lebanon. Rev Rhum Engl Ed 1997;64:459-464
9. Howe HS, Zhao L, Song YW, Springer L, Edmonds J, Gu J, et al. Seronegative spondyloarthropathy - studies from the Asia Pacific region. Ann Acad Med Singapore 2007;36:135-141 (Pubitemid 46640266)
10. Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL, et al. Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) - extended report. Rheumatology 2008;67:782-788
11. Burgos-Vargas R. Undifferentiated spondyloarthritis: A global perspective. Curr Rheumatol Rep 2007;9:361-366
12. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-783
13. Rudwaleit M, van der Heijde D, Landewé R, et al. New ASAS classification criteria for peripheral spondyloarthritis [abstract]. Ann Rheum Dis 2009;68 Suppl3:127.
14. Sampaio-Barros P, Bortoluzzo AB, Conde RA, Costallat LTL, Samara AM, Bértolo MB. Undifferentiated spondyloarthritis: A long-term follow-up. J Rheumatol 2010;37:1195-1199
15. Zeidler H, Mau W, Khan MA. Undifferentiated spondyloarthropathies. Rheum Dis Clin North Am 1992;18:187-202.
16. Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988;15:1109-1114
17. Kumar A, Bansal M, Srivastava DN, Pandhi A, Menon A, Mehra NK, et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int 2001;20:221-224
18. Khan MA, van der Linden S, Kushner I. Symptomatic ankylosing spondylitis without radiographic sacroiliitis in B27 positive relatives. Clin Res 1983;31:804A.
19. Prakash S, Bansal R, Rajgopalan P, Malaviya AN. Immunological studies in seronegative spondyloarthropathies. Br J Rheumatol 1983;22:146-150
20. Burns TM, Calin A. Undifferentiated spondyloarthropathy. In: Calin A, editor. Spondyloarthropathies. Orlando, FL: Grune & Stratton; 1984:253-264
21. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368
22. Sampaio-Barros PD, Bertolo MB, Kraemer MH, Marques-Neto JF, Samara AM. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001;20:201-206
23. Sany J, Rosenberg F, Panis G, Serre H. Unclassified HLA-B27 inflammatory rheumatic diseases: followup of 23 patients. Arthritis Rheum 1980;23:258-259
24. Schattenkirchner M, Krüger K. Natural course and prognosis of HLA-B27-positive oligoarthritis. Clin Rheumatol 1987;6 Suppl 2:83-86
25. Huerta-Sil G, Casasola-Vargas JC, Londoño JD, Rivas-Ruíz R, Chávez J, Pacheco-Tena C, et al. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2006;65:642-646
26. Collantes E, Veroz R, Escudero A, Muñoz E, Muñoz MC, Cisnal A, et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2000;67:516-520
27. Hall MA, Burgos-Vargas R, Ansell BM. Sacroiliitis in juvenile chronic arthritis: a 10-year follow-up. Clin Exp Rheumatol 1987;5 Suppl:65-67
28. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 1989;16:192-197 (Pubitemid 19085224)
29. Cabral DA, Oen KG, Petty RE. SEA syndrome revisited: a longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. J Rheumatol 1992;19:1282-1285
30. Burgos-Vargas R, Vázquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 1995;38:835-844
31. Sambrook P, McGuigan L, Champion D, Edmonds J, Fleming A, Portek I. Clinical features and followup study of HLA-B27 positive patients presenting with peripheral arthritis. J Rheumatol 1985;12:526-528 (Pubitemid 15004953)
32. Dubost JJ, Sauvezie B. Late onset peripheral spondyloarthropathy. J Rheumatol 1989;16:1214-1217
33. Olivieri I, Padula A, Pierro A, Favaro L, Oranges GS, Ferri S. Late onset undifferentiated seronegative spondyloarthropathy. J Rheumatol 1995;22:899-903.
34. Caplanne D, Tubach F, Le Parc JM. Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Ann Rheum Dis 1997;56:176-179 (Pubitemid 27144201)
35. Olivieri I, Salvarani C, Cantini F, Ciancio G, Padula A. Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol 2001;13:280-284
36. Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY. Features of spondyloarthritis around the world [review]. Rheum Dis Clin North Am 1998;24:753-770 (Pubitemid 28524022)
37. Hajjaj-Hassouni N, Burgos-Vargas R. Ankylosing spondylitis and reactive arthritis in the developing world. Best Pract Res Clin Rheumatol 2008;22:709-712
38. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61-66 (Pubitemid 36384722)
39. Rudwaleit M, Listing J, Brandt J, Braun J, Sieper. Prediction of a major clinical response (BASDAI 50) to tumour necrosismajor clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004;63:665-670
40. Sieper J, Rudwaleit M. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers? Ann Rheum Dis 2005;64 Suppl 4:iv61-4.
41. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-543
42. Heuft-Dorenbosch L, Landewé R, Weijers R, Houben H, van der Linden S, Jacobs P, et al. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007;66:92-98
43. Brandt HC, Spiller I, Song IH, Vahldiek JL, Rudwaleit M, Sieper J. Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis 2007;66:1479-1484
44. Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-3418
45. Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-727
46. Rojas-Vargas M, Muñoz-Gomariz E, Escudero A, Font P, Zarco P, Almodovar R, et al, and Registro Español de Espondiloartritis de la Sociedad Española de Reumatología Working Group. First signs and symptoms of spondyloarthritis - data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology 2009;48:404-409
47. Vazquez-Mellado J, Font P, Azevedo V, et al. Disease patterns in patients with spondyloarthropathies (SpA) from Iberoamérica (IBA): The Respondia group report [abstract]. Ann Rheum Dis 2008;67 Suppl II:627.